News | November 13, 2008

MP3 Headphones Interfere with Implantable Defibrillators, Pacemakers

November 14, 2008 - Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators (ICDs) may interfere with these devices, according to research presented this week at the American Heart Association's Scientific Sessions 2008 in New Orleans.

Researchers investigated the effects of MP3 digital music player headphones, most of which contain the magnetic substance neodymium, on the operation of implanted cardiac devices. Earlier this year an FDA report concluded that interactions between MP3 players, such as the popular iPod, and implanted cardiac devices are unlikely to occur.

"We became interested in knowing whether the headphones which contain magnets - not the MP3 players, themselves - would interact with implanted cardiac devices," said William H. Maisel, M.D., MPH, senior author of the study and director of the Medical Device Safety Institute at Beth Israel Medical Center in Boston, MA.

Maisel said doctors traditionally use magnets in the clinical setting to test pacemakers, which treat slow heart rhythms. When exposed to magnets, these devices automatically pace, sending low-energy signals to the heart to make it beat. Defibrillators, which treat slow and dangerously fast heart rhythms, send either low- or high-energy signals to the heart. However, ICDs near magnets may temporarily stop looking for abnormal heart rhythms, researchers said.

Implanted cardiac devices that react in these ways to magnets outside the clinical setting can be potentially dangerous for patients who rely on their lifesaving technologies.

Researchers tested eight different models of MP3 player headphones (including both the clip-on and earbud variety) with iPods on 60 defibrillator and pacemaker patients.

"We placed the headphones on the patients' chests, directly over where their devices are located, monitoring them for evidence of an interaction," Dr. Maisel said.

The researchers found a detectable interference with the device by the headphones in 14 patients, (23 percent). Specifically, they observed that 15 percent of the pacemaker patients and 30 percent of the defibrillator patients had a magnet response, Dr. Maisel said.

"For patients with pacemakers, exposure to the headphones can force the device to deliver signals to the heart, causing it to beat without regard to the patients' underlying heart rhythm," he said. "Exposure of a defibrillator to the headphones can temporarily deactivate the defibrillator." In most cases, he said removal of the headphones restores normal device function.

The researchers also tested the magnetic field strengths of each of the headphone models using a gauss meter, which measures the units of magnetic charge produced.

Field strength of 10 gauss at the site of the pacemaker or defibrillator has the potential to interact with the implantable device. The researchers found that some of the headphones had field strengths as high as 200 gauss or more.

"Even at those high levels, we did not observe any interactions when the headphones were at least 3 cm, or about 1.2 inches, from the skin's surface," Dr. Maisel said. "Patients should not focus on the brands we tested, but instead should simply be instructed to keep their headphones at least 3 cm from their implantable devices."

Instead, researchers said patients should not place headphones in their pocket or drape them over their chest.

"For family members or friends of patients with implantable defibrillators, they should avoid wearing headphones and resting their head right on top of someone's device," he said.

In two unrelated studies, researchers did not report adverse heart-related effects on implantable cardiac devices from other devices.

Researchers in Hyannis, MA, found that cell phones equipped with wireless technology known as Bluetooth and pills swallowed to view internal organs are unlikely to interfere with pacemakers or ICDs.

Likewise, California researchers determined that electromagnetic interference from personal devices including iPod, iPod nano, iPhone, some cell phones (with and without Bluetooth technology), electric blankets, and hand-held airport security metal detectors did not cause adverse effects to patients with pacemakers or ICD.

For more information: www.americanheart.org


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now